Lars Ynddal
Impact in
-
- Diabetes Treatment and Management
-
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Receptor Mechanisms and Signaling 5
- Peroxisome Proliferator-Activated Receptors 4
-
- Growth Hormone and Insulin-like Growth Factors 5
- Pituitary Gland Disorders and Treatments 3
- Diabetes Treatment and Management 2
- Co-authors
- Steen Honoré Hansen (1 shared paper)John P. Mogensen (5 shared papers)Lone Jeppesen (4 shared papers)Christian L. Brand (3 shared papers)Erik Max Wulff (4 shared papers)Ingrid Pettersson (4 shared papers)Jan Fleckner (4 shared papers)Per Sauerberg (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (7 papers)Growth Hormone & IGF Research (3 papers)Pharmaceutical Research (1 paper)Science Translational Medicine (1 paper)Scientific Reports (1 paper)
- Partner nations
- DenmarkSwitzerlandUnited States
In The Last Decade
Lars Ynddal
18 papers receiving 480 citations
Peers
Comparison fields: 5 of 69
- Endocrinology, Diabetes and Metabolism 127
- Biochemistry 39
- Physiology 22
- Molecular Biology 304
- Pharmacology 62
Countries citing papers authored by Lars Ynddal
This map shows the geographic impact of Lars Ynddal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ynddal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ynddal more than expected).
Fields of papers citing papers by Lars Ynddal
This network shows the impact of papers produced by Lars Ynddal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ynddal. The network helps show where Lars Ynddal may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Ynddal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 126 | |
| 2 | 2007 | 44 | |
| 3 | 2002 | 40 | |
| 4 | 2021 | 33 | |
| 5 | 2003 | 29 | |
| 6 | 2003 | 28 | |
| 7 | 2009 | 26 | |
| 8 | 2003 | 23 | |
| 9 | 2006 | 23 | |
| 10 | 1995 | 22 | |
| 11 | 1999 | 18 | |
| 12 | 2003 | 18 | |
| 13 | 2007 | 18 | |
| 14 | 2000 | 13 | |
| 15 | 2001 | 9 | |
| 16 | 2001 | 9 | |
| 17 | 2025 | 3 | |
| 18 | 1998 | 2 |
About Lars Ynddal
Lars Ynddal is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Cellular and Molecular Neuroscience, Organic Chemistry and Surgery, having authored 18 papers that have together received 484 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Neuropeptides and Animal Physiology (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Pituitary Gland Disorders and Treatments (3 papers), Pancreatic function and diabetes (2 papers), Adipose Tissue and Metabolism (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (127 citations), Biochemistry (39 citations), Physiology (22 citations), Molecular Biology (304 citations) and Pharmacology (62 citations). Lars Ynddal has collaborated with scholars based in Denmark, Switzerland and United States. Frequent co-authors include Steen Honoré Hansen, John P. Mogensen, Lone Jeppesen, Christian L. Brand, Erik Max Wulff, Ingrid Pettersson, Jan Fleckner, Per Sauerberg, L. Anders Svensson and Paul S. Bury. Their work appears in journals such as Journal of Medicinal Chemistry, Growth Hormone & IGF Research, Pharmaceutical Research, Science Translational Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.